aTTom (adjuvant Tamoxifen-To offer more?): Randomized trial of 10 versus 5 years of adjuvant tamoxifen among 6,934 women with estrogen receptor-positive (ER+) or ER untested breast cancer-Preliminary results (2008)

First Author: Gray R

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1200/jco.2008.26.15_suppl.513

Publication URI: http://dx.doi.org/10.1200/jco.2008.26.15_suppl.513

Type: Journal Article/Review

Parent Publication: Journal of Clinical Oncology

Issue: 15_suppl